Literature DB >> 6690082

O6-alkylguanine-DNA alkyltransferase activity in human brain and brain tumors.

O Wiestler, P Kleihues, A E Pegg.   

Abstract

It was found that extracts from human brain catalyzed the transfer of methyl groups from O6-methylguanine in methylated double-stranded DNA to a cysteine residue in a protein of mol. wt. approximately 22 000. This O6-alkylguanine-DNA alkyltransferase had properties similar to those previously characterized from rodent liver, human liver, cultured human cells and E. coli. The alkyltransferase activity of human brain was considerably greater than that reported for rat brain, but was significantly less than the activities found in human liver and other tissues. The activity was found in both normal brain samples (peritumoral material which contained no tumor infiltration) and in a variety of brain tumors. The highest activity was found in meningeomas and neurinomas, but most tumors with the exception of some gliomas had higher activities than the normal brain. All 23 tumor samples examined in this study had alkyltransferase activity in contrast to published reports showing that approximately 35% of human brain-tumor-derived lines grown in culture lacked this activity. This discrepancy may be due to the cellular polymorphism of the tumors, but also suggests that complete lack of the alkyltransferase is not a common occurrence in human brain tumors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6690082     DOI: 10.1093/carcin/5.1.121

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  29 in total

1.  Lack of the DNA repair protein O6-methylguanine-DNA methyltransferase in histologically normal brain adjacent to primary human brain tumors.

Authors:  J R Silber; A Blank; M S Bobola; B A Mueller; D D Kolstoe; G A Ojemann; M S Berger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  O6-Alkylguanine-DNA alkyltransferase content in synchronised human cancer cells.

Authors:  P Coccia; S Sen; E Erba; P Pagani; C Marinello; M D'Incalci
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Repair of O6-ethylguanine in DNA protects rat 208F cells from tumorigenic conversion by N-ethyl-N-nitrosourea.

Authors:  J Thomale; N H Huh; P Nehls; G Eberle; M F Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

4.  Purification to homogeneity and partial amino acid sequence of a fragment which includes the methyl acceptor site of the human DNA repair protein for O6-methylguanine.

Authors:  G N Major; E J Gardner; A F Carne; P D Lawley
Journal:  Nucleic Acids Res       Date:  1990-03-25       Impact factor: 16.971

Review 5.  Genomic damage and its repair in young and aging brain.

Authors:  K S Rao
Journal:  Mol Neurobiol       Date:  1993       Impact factor: 5.590

6.  Expression of O-Alkylguanine-DNA Alkyltransferase in Normal and Malignant Bladder Tissue of Egyptian Patients.

Authors:  Abir A Saad; Heba Sh Kassem; Andrew C Povey; Geoffrey P Margison
Journal:  J Nucleic Acids       Date:  2010-10-17

7.  Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea.

Authors:  G M Felker; H S Friedman; M E Dolan; R C Moschel; C Schold
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

8.  O6-Alkylguanine-DNA alkyltransferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea.

Authors:  T P Brent; P J Houghton; J A Houghton
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

9.  O6 alkylguanine-DNA alkyltransferase activity in human myeloid cells.

Authors:  S L Gerson; K Miller; N A Berger
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

10.  Enhancement of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) toxicity by acetohydroxamic acid analogues of 3-nitropyrazole in vitro.

Authors:  R T Mulcahy; D J Wustrow; R R Hark; A S Kende
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.